Cargando…

Thromboinflammation and the hypercoagulability of COVID‐19

Detalles Bibliográficos
Autores principales:	Connors, Jean M., Levy, Jerrold H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770920/ https://www.ncbi.nlm.nih.gov/pubmed/32302453 http://dx.doi.org/10.1111/jth.14849

Ejemplares similares

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19
por: Goshua, George, et al.
Publicado: (2021)

Thromboinflammation response to tocilizumab in COVID‐19
por: Gergi, Mansour, et al.
Publicado: (2020)

Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability
por: Zarrouk, Sinda, et al.
Publicado: (2021)

COVID-19 and Thromboinflammation: Is There a Role for Statins?
por: Ferrari, Filipe, et al.
Publicado: (2021)

Thromboinflammation in COVID-19 acute lung injury
por: Mitchell, William Beau
Publicado: (2020)

Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation
por: Lind, Stuart E.
Publicado: (2021)

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
por: Gu, Sean X., et al.
Publicado: (2020)

Thromboinflammation and COVID-19: The Role of Exercise in the Prevention and Treatment
por: Batatinha, Helena Angelica Pereira, et al.
Publicado: (2020)

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
por: Hoffmann, Johannes N, et al.
Publicado: (2007)

COVID-19 and its implications for thrombosis and anticoagulation
por: Connors, Jean M., et al.
Publicado: (2020)

433. Thromboinflammation in COVID-19 and association with death in patients on ECMO
por: Platt, Andrew, et al.
Publicado: (2023)

Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19
por: Peerschke, Ellinor I., et al.
Publicado: (2021)

Platelets, Thromboinflammation and Neurovascular Disease
por: Sun, Ying, et al.
Publicado: (2022)

The coagulopathy, endotheliopathy, and vasculitis of COVID-19
por: Iba, Toshiaki, et al.
Publicado: (2020)

Indicators of hypercoagulability and recurrent venous thromboembolism in the elderly: rethinking age and thrombophilia
por: Middeldorp, Saskia
Publicado: (2023)

Platelets and Immune Responses During Thromboinflammation
por: Mezger, Matthias, et al.
Publicado: (2019)

Thromboinflammation in long COVID—the elusive key to postinfection sequelae?
por: Nicolai, Leo, et al.
Publicado: (2023)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

Chemokines, molecular drivers of thromboinflammation and immunothrombosis
por: Leberzammer, Julian, et al.
Publicado: (2023)

Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
por: Potere, Nicola, et al.
Publicado: (2023)

Editorial commentary: Vascular injury in acute infections and COVID-19: everything old is new again
por: Levy, Jerrold H., et al.
Publicado: (2021)

Interpreting recent clinical studies for COVID-19: A continual process with more new data
por: Connors, Jean M., et al.
Publicado: (2022)

COVID‐19 hypothesis: Activated protein C for therapy of virus‐induced pathologic thromboinflammation
por: Griffin, John H., et al.
Publicado: (2020)

“War to the knife” against thromboinflammation to protect endothelial function of COVID-19 patients
por: Guglielmetti, Gabriele, et al.
Publicado: (2020)

Thromboinflammation in COVID‐19: Can α(2)‐macroglobulin help to control the fire?
por: Seitz, Rainer, et al.
Publicado: (2021)

Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation
por: Díaz-García, Elena, et al.
Publicado: (2022)

Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation
por: Schiavello, Martina, et al.
Publicado: (2023)

Acute to post-acute COVID-19 thromboinflammation persistence: Mechanisms and potential consequences
por: Martins-Gonçalves, Remy, et al.
Publicado: (2023)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients()
por: Goswami, Julie, et al.
Publicado: (2021)

Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19
por: Hottz, Eugenio D., et al.
Publicado: (2022)

Editorial: Platelets and Immune Responses During Thromboinflammation
por: Schattner, Mirta, et al.
Publicado: (2020)

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
por: Marin Oyarzún, Cecilia P., et al.
Publicado: (2019)

Complement inhibition in biomaterial- and biosurface-induced thromboinflammation
por: Ekdahl, Kristina N., et al.
Publicado: (2016)

Thromboinflammation in coronavirus disease 2019: The clot thickens
por: Iffah, Raayma, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s6k76d7j72qenkm7de6tqou3vh